230 related articles for article (PubMed ID: 29487821)
1. Effects of lipid-lowering agents on diabetic retinopathy: a Meta-analysis and systematic review.
Shi R; Zhao L; Wang F; Liu F; Chen Z; Li R; Liu Y; Lin R
Int J Ophthalmol; 2018; 11(2):287-295. PubMed ID: 29487821
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia and Diabetic Macular Edema: A Systematic Review and Meta-Analysis.
Das R; Kerr R; Chakravarthy U; Hogg RE
Ophthalmology; 2015 Sep; 122(9):1820-7. PubMed ID: 26150053
[TBL] [Abstract][Full Text] [Related]
5. Fibrates and statins in the treatment of diabetic retinopathy.
Ansquer JC; Crimet D; Foucher C
Curr Pharm Biotechnol; 2011 Mar; 12(3):396-405. PubMed ID: 20939802
[TBL] [Abstract][Full Text] [Related]
6. Fenofibrate for diabetic retinopathy.
Kataoka SY; Lois N; Kawano S; Kataoka Y; Inoue K; Watanabe N
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013318. PubMed ID: 37310870
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
8. Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review.
Mozetic V; Freitas CG; Riera R
JMIR Res Protoc; 2017 Feb; 6(2):e30. PubMed ID: 28228373
[TBL] [Abstract][Full Text] [Related]
9. Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis.
Mozetic V; Pacheco RL; Latorraca COC; Riera R
Diabetol Metab Syndr; 2019; 11():92. PubMed ID: 31719846
[TBL] [Abstract][Full Text] [Related]
10. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.
Xie J; Ikram MK; Cotch MF; Klein B; Varma R; Shaw JE; Klein R; Mitchell P; Lamoureux EL; Wong TY
JAMA Ophthalmol; 2017 Jun; 135(6):586-593. PubMed ID: 28472362
[TBL] [Abstract][Full Text] [Related]
11. Single herbal medicine for diabetic retinopathy.
Zhang HW; Zhang H; Grant SJ; Wan X; Li G
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD007939. PubMed ID: 30566763
[TBL] [Abstract][Full Text] [Related]
12. Anti-vascular endothelial growth factor for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Evans JR
Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
[TBL] [Abstract][Full Text] [Related]
13. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
[TBL] [Abstract][Full Text] [Related]
14. Laser photocoagulation for proliferative diabetic retinopathy.
Evans JR; Michelessi M; Virgili G
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.
Braithwaite T; Nanji AA; Lindsley K; Greenberg PB
Cochrane Database Syst Rev; 2014 May; 2014(5):CD007325. PubMed ID: 24788977
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of diabetic retinopathy events associated with glucose-lowering drugs in patients with type 2 diabetes mellitus: A network meta-analysis.
Tang H; Li G; Zhao Y; Wang F; Gower EW; Shi L; Wang T
Diabetes Obes Metab; 2018 May; 20(5):1262-1279. PubMed ID: 29369494
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
19. Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database.
Kawasaki R; Konta T; Nishida K
Diabetes Obes Metab; 2018 Oct; 20(10):2351-2360. PubMed ID: 29790265
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
